Results 121 to 130 of about 2,643,317 (205)

New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia

open access: yesHaematologica, 1999
We report a new chromosomal reciprocal translocation t(5;10)(q33;q22) in a 49-year-old man with atypical chronic myeloid leukemia (a-CML) and history of occupational exposure to petroleum products including benzene and other hydrocarbons.
S Siena   +8 more
doaj  

Evaluating survival after allogeneic bone marrow transplant for chronic myeloid leukaemia in chronic phase: a comparison of transplant versus no transplant in cohort of 258 patients first seen in Italy between 1984 and 1986.

open access: yes, 1993
Information on the outcome of allogeneic bone marrow transplant (BMT) for chronic myeloid leukaemia (CML) was previously provided by BMT centres or registries.
The Italian Cooperative Study Group on Chronic Myeloid Leukemia   +1 more
core  

Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia

open access: yesHaematologica, 2014
Manja Meggendorfer   +6 more
doaj   +1 more source

A Rare Onset of T-Lymphoid Blast Crisis in Chronic Myeloid Leukemia with Two Distinct Blast Populations

open access: yesHematology Reports
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by bone marrow expansion and the proliferation of one or more myeloid cell lineages, predominantly driven by the expression of the constitutively active fusion product tyrosine
Alessandra Mongia   +7 more
doaj   +1 more source

A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.

open access: yes, 1999
BACKGROUND AND OBJECTIVE: Alpha-interferon (alphaIFN) can induce cytogenetic remissions in chronic myeloid leukemia (CML). Hemopoietic progenitors can be collected from the marrow in remission and utilized for autologous repopulation after high dose ...
Russo D   +13 more
core  

Abnormalities affecting tyrosine kinase signalling in atypical myeloproliferative disorders [PDF]

open access: yes, 2009
The myeloproliferative disorders (MPDs) are a group of haematopoietic stem cell diseases, characterised by proliferation of one or more cells of the myeloid lineage.
Hidalgo-Curtis, Claire
core  

A 19-year-old patient with atypical chronic myeloid leukemia. [PDF]

open access: yesAnn Hematol, 2020
Ernst P   +12 more
europepmc   +1 more source

miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia

open access: yesScientific Reports
Morgana is a ubiquitous HSP90 co-chaperone protein coded by the CHORDC1 gene. Morgana heterozygous mice develop with age a myeloid malignancy resembling human atypical myeloid leukemia (aCML), now renamed MDS/MPN with neutrophilia.
Pietro Poggio   +18 more
doaj   +1 more source

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors [PDF]

open access: yes, 2002
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835) point mutations, are present in approximately one third of patients with acute myeloid leukemia (AML) and have been associated with an increased relapse rate.
Kottaridis, P.D.   +5 more
core  

Home - About - Disclaimer - Privacy